3qxt
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[Image:3qxt.jpg|left|200px]] | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3qxt", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3qxt| PDB=3qxt | SCENE= }} | {{STRUCTURE_3qxt| PDB=3qxt | SCENE= }} | ||
| - | |||
===Structure of an Anti-Methotrexate CDR1-3 Graft VHH Antibody in Complex with Methotrexate=== | ===Structure of an Anti-Methotrexate CDR1-3 Graft VHH Antibody in Complex with Methotrexate=== | ||
| - | |||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_21557375}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 21557375 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_21557375}} | {{ABSTRACT_PUBMED_21557375}} | ||
| Line 22: | Line 7: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:021557375</ref><references group="xtra"/> | + | <ref group="xtra">PMID:021557375</ref><references group="xtra"/><references/> |
[[Category: Lama glama]] | [[Category: Lama glama]] | ||
[[Category: Fanning, S W.]] | [[Category: Fanning, S W.]] | ||
Revision as of 07:48, 16 May 2013
Structure of an Anti-Methotrexate CDR1-3 Graft VHH Antibody in Complex with Methotrexate
Template:ABSTRACT PUBMED 21557375
About this Structure
3qxt is a 2 chain structure with sequence from Lama glama. Full crystallographic information is available from OCA.
Reference
- Fanning SW, Horn JR. An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop. Protein Sci. 2011 Jul;20(7):1196-207. doi: 10.1002/pro.648. Epub 2011 May, 23. PMID:21557375 doi:10.1002/pro.648
